MedPath

Effect of fenugreek on blood cholesterol and other lipids in patients with diabetes

Phase 3
Conditions
Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Registration Number
CTRI/2024/02/062691
Lead Sponsor
Dr S V Madhu
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Mild to moderate hypertriglyceridemia( serum triglycerides more than 150 but less than 500 mg per dl

2.On a stable dose of statins for three months or not on statins

3. BMI more than 25 kilograms per square meters

Exclusion Criteria

1.Any lipid lowering therapy other than statins

2.Hypothyroidism or hyperthyroidism

3.History of any macrovascular complications of diabetes including coronary artery disease, cerebrovascular disease of peripheral arterial disease

4.Pregnancy or lactation

5.History of cancer, pancreatitis, or any major illness of the liver, kidney and central nervous system

6.Subjects on systemic glucocorticoids, beta blockers, thiazides and nicotinic acid

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br/ ><br>Postprandial triglyceride levels in fenugreek and control group <br/ ><br>Timepoint: After 90 days of study intervention
Secondary Outcome Measures
NameTimeMethod
Change in fasting & post prandial glucose, <br/ ><br>Change in weight, <br/ ><br>Change in waist circumference,Change in fasting triglycerides <br/ ><br>Timepoint: End of study (90 days)
© Copyright 2025. All Rights Reserved by MedPath